RAILY AESMED released its interim results, with a loss attributable to shareholders of 7.57 million yuan, an increase of 368.15% year-on-year
I'm PortAI, I can summarize articles.
RAILY AESMED released its interim results for the period ending June 30, 2025, reporting revenue of RMB 84.598 million, a year-on-year decrease of 27.99%; loss attributable to equity holders of the parent company was RMB 7.57 million, a year-on-year increase of 368.15%; loss per share was 1.36 cents. Revenue from medical beauty services was approximately RMB 74.90 million, a year-on-year decrease of 9.7%, mainly due to a reduction in the number of active customers caused by intense competition
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments